Issue Date | Title | Author(s) |
2023-02 | Immunotherapeutic targets in non-small cell lung cancer. | Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
2020-01 | The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies. | Sadeghi Rad, H; Bazaz, SR; Monkman, J; Ebrahimi Warkiani, M; Rezaei, N; O'Byrne, K; Kulasinghe, A |
2022-07 | Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. | Kapeleris, J; Müller Bark, J; Ranjit, S; Irwin, D; Hartel, G; Warkiani, ME; Leo, P; O'Leary, C; Ladwa, R; O'Byrne, K; Hughes, BGM; Punyadeera, C |
2020-10 | Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Oleary, C; Vela, I; Leo, P; Sternes, P; O'Byrne, K; Punyadeera, C |
2022 | IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. | Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Teo, SM; Rodrigues Rossi, G; McCulloch, TR; Nalos, M; Raei, M; Razavi, A; Ghasemian, R; Gheibi, M; Roozbeh, F; Sly, PD; Spann, KM; Chew, KY; Zhu, Y; Xia, Y; Wells, TJ; Senegaglia, AC; Kuniyoshi, CL; Franck, CL; Dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, TM; Kuan, WS; Jee, Y; Iredell, J; O'Byrne, K; Fraser, JF; Davis, MJ; Belz, GT; Warkiani, ME; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, KR; Tang, B |
2022 | Understanding the tumor microenvironment in head and neck squamous cell carcinoma. | Rad, HS; Shiravand, Y; Radfar, P; Ladwa, R; Perry, C; Han, X; Warkiani, ME; Adams, MN; Hughes, BG; O'Byrne, K; Kulasinghe, A |
2024 | Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies placental dysfunction signatures. | Stylianou, N; Sebina, I; Matigian, N; Monkman, J; Doehler, H; Röhl, J; Allenby, M; Nam, A; Pan, L; Rockstroh, A; Sadeghirad, H; Chung, K; Sobanski, T; O'Byrne, K; Almeida, ACSF; Rebutini, PZ; Machado-Souza, C; Stonoga, ETS; Warkiani, ME; Salomon, C; Short, K; McClements, L; de Noronha, L; Huang, R; Belz, GT; Souza-Fonseca-Guimaraes, F; Clifton, V; Kulasinghe, A |
2023 | Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. | Sadeghirad, H; Liu, N; Monkman, J; Ma, N; Cheikh, BB; Jhaveri, N; Tan, CW; Warkiani, ME; Adams, MN; Nguyen, Q; Ladwa, R; Braubach, O; O'Byrne, K; Davis, M; Hughes, BGM; Kulasinghe, A |